AwardTape · Defense awards · Medical · Drugs and biologicals · W911QY13C0056
W911QY13C0056: -$317K definitive contract to Dynport Vaccine Company LLC
Dynport Vaccine Company LLC holds a definitive contract from Department of the Army with -$317K obligated since Oct 2023 and $117.6M obligated over its life, against a ceiling of $258.1M. Latest action May 12, 2026.
Program reporting - technical
| PIID | W911QY13C0056 |
|---|---|
| Type | definitive contract |
| Company | Dynport Vaccine Company LLC |
| Agency | Department of the Army |
| Contracting office | W6QK ACC-APG |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 541711 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| Obligated since Oct 2023 | -$317K |
| Total obligated (lifetime) | $117.6M |
| Ceiling (base and all options) | $258.1M |
| Base date | May 9, 2013 |
| Latest action | May 12, 2026 |
| End date | Mar 11, 2027 |
| Actions since Oct 2023 | 6 |
| Pricing | Cost plus fixed fee |
| Competition | Full and open competition |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial